BBG Advanced Therapies provides a comprehensive suite of RUO and cGMP-qualified assays to support the development and biomanufacturing of cell- and tissue-based products.
Experienced scientists collaborate closely with biopharma and research partners to develop, transfer, and validate custom assays that confirm the safety, purity, and potency of advanced therapies. From early research through cGMP release, testing services ensure your data withstands regulatory and scientific scrutiny.
BBG Advanced Therapies delivers testing solutions designed for precision, reproducibility, and regulatory alignment. Each assay is performed under rigorous quality control, leveraging integrated capabilities across starting materials, manufacturing, and research support.
Our team offers deep experience in developing custom assays and performing tech transfers for both investigational and commercial programs—ensuring results that are consistent, compliant, and clinically meaningful.
A full range of safety assays verifies that advanced therapy products are free of contamination and safe for clinical use.
Analytical testing methods define the physical and biological attributes of advanced therapy products.
BBG Advanced Therapies is a pioneer in potency assay methodology, able to develop custom potency assays or tech-transferred client methods to support potency determination—a critical requirement for regulatory submission and lot release.
The integrated collaboration between BBG Advanced Therapies’ testing and quality teams accelerates the introduction of new assays and products. Phase-appropriate, risk-based testing solutions are designed to assure the safety, purity, identity, and potency of cell- and tissue-based products.
This has been our guiding principle for more than 50 years—ensuring quality by advancing laboratory excellence through validated methods, controlled environments, and a continuous focus on process improvement.
